Clayton Biotechnologies is currently working with a significant portfolio of technologies available for licensing in the biomedical domain. We are actively seeking third party arrangements to commercialize these technologies. Such arrangements may involve a license agreement with an existing biotech or pharma company. In some cases, the technology may require further evaluation and/or development by a commercial company, which can be covered by either a short-term option agreement and/or a collaborative research agreement. Also, Clayton Biotechnologies has experience working with investors and entrepreneurs, especially in situations where a technology constitutes the appropriate foundation of a start-up venture.
Our offered technologies are covered by pending or granted patents, and generally with international patent protection.
If you are interested in gathering more information on one of our technologies, please feel free to contact us.